ASX - By Stock
|
1AI |
Re:
Other views
|
|
oldinvestor
|
35 |
31K |
4 |
13/08/19 |
13/08/19 |
ASX - By Stock
|
35
|
31K
|
4
|
|
ASX - By Stock
|
1AI |
Re:
Other views
|
|
oldinvestor
|
35 |
31K |
2 |
11/08/19 |
11/08/19 |
ASX - By Stock
|
35
|
31K
|
2
|
|
ASX - By Stock
|
1AI |
Re:
Other views
|
|
oldinvestor
|
35 |
31K |
7 |
10/08/19 |
10/08/19 |
ASX - By Stock
|
35
|
31K
|
7
|
|
ASX - By Stock
|
1AI |
INHERENT PROBLEMS with pd trials using brain surgery
|
|
oldinvestor
|
6 |
3.2K |
13 |
15/05/19 |
15/05/19 |
ASX - By Stock
|
6
|
3.2K
|
13
|
|
ASX - By Stock
|
1AI |
can lct even give a success rate? that's the first thing i'd ask and i have pd.
|
|
oldinvestor
|
10 |
6.0K |
2 |
12/03/19 |
12/03/19 |
ASX - By Stock
|
10
|
6.0K
|
2
|
|
ASX - By Stock
|
1AI |
i want to see the individual patient data
|
|
oldinvestor
|
0 |
510 |
8 |
20/10/18 |
20/10/18 |
ASX - By Stock
|
0
|
510
|
8
|
|
ASX - By Stock
|
1AI |
Re:
Ann: LCT to sell JV Shares and receive DIABECELL licence
|
|
oldinvestor
|
127 |
55K |
1 |
12/02/18 |
12/02/18 |
ASX - By Stock
|
127
|
55K
|
1
|
|
ASX - By Stock
|
1AI |
Re:
Tuesday, June 13, 2017 Enhanced Delivery of GDNF to Putamen in PD Shows No Clinical Benefit in Blind
|
|
oldinvestor
|
9 |
3.7K |
1 |
18/01/18 |
18/01/18 |
ASX - By Stock
|
9
|
3.7K
|
1
|
|
ASX - By Stock
|
1AI |
Tuesday, June 13, 2017 Enhanced Delivery of GDNF to Putamen in PD Shows No Clinical Benefit in Blind
|
|
oldinvestor
|
9 |
3.7K |
1 |
11/01/18 |
11/01/18 |
ASX - By Stock
|
9
|
3.7K
|
1
|
|
ASX - By Stock
|
1AI |
Re:
Phase1 week210(?) questions and patient 1 discussion, i'm a broken record and old
|
|
oldinvestor
|
12 |
4.6K |
0 |
25/12/17 |
25/12/17 |
ASX - By Stock
|
12
|
4.6K
|
0
|
|
ASX - By Stock
|
1AI |
Phase1 week210(?) questions and patient 1 discussion, i'm a broken record and old
|
|
oldinvestor
|
12 |
4.6K |
1 |
25/12/17 |
25/12/17 |
ASX - By Stock
|
12
|
4.6K
|
1
|
|
ASX - By Stock
|
1AI |
Re:
i've been looking at the phase1 data, does anyone see anything strange in this130week graph
|
|
oldinvestor
|
7 |
2.6K |
1 |
20/12/17 |
20/12/17 |
ASX - By Stock
|
7
|
2.6K
|
1
|
|
ASX - By Stock
|
1AI |
Re:
i've been looking at the phase1 data, does anyone see anything strange in this130week graph
|
|
oldinvestor
|
7 |
2.6K |
1 |
19/12/17 |
19/12/17 |
ASX - By Stock
|
7
|
2.6K
|
1
|
|
ASX - By Stock
|
1AI |
i've been looking at the phase1 data, does anyone see anything strange in this130week graph
|
|
oldinvestor
|
7 |
2.6K |
0 |
19/12/17 |
19/12/17 |
ASX - By Stock
|
7
|
2.6K
|
0
|
|
ASX - By Stock
|
1AI |
Re:
AGM
|
|
oldinvestor
|
182 |
58K |
3 |
29/11/17 |
29/11/17 |
ASX - By Stock
|
182
|
58K
|
3
|
|
ASX - By Stock
|
1AI |
Re:
AGM
|
|
oldinvestor
|
182 |
58K |
1 |
21/11/17 |
21/11/17 |
ASX - By Stock
|
182
|
58K
|
1
|
|
ASX - By Stock
|
1AI |
Re:
AGM
|
|
oldinvestor
|
182 |
58K |
4 |
21/11/17 |
21/11/17 |
ASX - By Stock
|
182
|
58K
|
4
|
|
ASX - By Stock
|
1AI |
Re:
AGM
|
|
oldinvestor
|
182 |
58K |
2 |
20/11/17 |
20/11/17 |
ASX - By Stock
|
182
|
58K
|
2
|
|
ASX - By Stock
|
1AI |
Re:
AGM
|
|
oldinvestor
|
182 |
58K |
2 |
20/11/17 |
20/11/17 |
ASX - By Stock
|
182
|
58K
|
2
|
|
ASX - By Stock
|
1AI |
Re:
Some TA
|
|
oldinvestor
|
54 |
23K |
1 |
20/11/17 |
20/11/17 |
ASX - By Stock
|
54
|
23K
|
1
|
|
ASX - By Stock
|
1AI |
Re:
I called LCT today..
|
|
oldinvestor
|
4 |
3.2K |
2 |
16/11/17 |
16/11/17 |
ASX - By Stock
|
4
|
3.2K
|
2
|
|
ASX - By Stock
|
1AI |
Re:
It's not over.
|
|
oldinvestor
|
7 |
3.0K |
4 |
14/11/17 |
14/11/17 |
ASX - By Stock
|
7
|
3.0K
|
4
|
|
ASX - By Stock
|
1AI |
Re:
research v. Phase II exam
|
|
oldinvestor
|
12 |
4.1K |
12 |
13/11/17 |
13/11/17 |
ASX - By Stock
|
12
|
4.1K
|
12
|
|
ASX - By Stock
|
1AI |
Re:
Ann: Results of LCT Parkinsons trial require further analysis
|
|
oldinvestor
|
163 |
71K |
2 |
12/11/17 |
12/11/17 |
ASX - By Stock
|
163
|
71K
|
2
|
|
ASX - By Stock
|
1AI |
Re:
Ann: Results of LCT Parkinsons trial require further analysis
|
|
oldinvestor
|
163 |
71K |
10 |
11/11/17 |
11/11/17 |
ASX - By Stock
|
163
|
71K
|
10
|
|
ASX - By Stock
|
1AI |
Re:
Ann: Results of LCT Parkinsons trial require further analysis
|
|
oldinvestor
|
163 |
71K |
6 |
11/11/17 |
11/11/17 |
ASX - By Stock
|
163
|
71K
|
6
|
|
ASX - By Stock
|
1AI |
Re:
Ann: Results of LCT Parkinsons trial require further analysis
|
|
oldinvestor
|
163 |
71K |
5 |
11/11/17 |
11/11/17 |
ASX - By Stock
|
163
|
71K
|
5
|
|
ASX - By Stock
|
1AI |
Re:
Ann: Results of LCT Parkinsons trial require further analysis
|
|
oldinvestor
|
163 |
71K |
4 |
11/11/17 |
11/11/17 |
ASX - By Stock
|
163
|
71K
|
4
|
|
ASX - By Stock
|
1AI |
Re:
Ann: Results of LCT Parkinsons trial require further analysis
|
|
oldinvestor
|
163 |
71K |
4 |
11/11/17 |
11/11/17 |
ASX - By Stock
|
163
|
71K
|
4
|
|
ASX - By Stock
|
1AI |
Re:
Maybe the graph is showing patient improvement?
|
|
oldinvestor
|
11 |
2.9K |
2 |
10/11/17 |
10/11/17 |
ASX - By Stock
|
11
|
2.9K
|
2
|
|
ASX - By Stock
|
1AI |
Re:
Ann: Results of LCT Parkinsons trial require further analysis
|
|
oldinvestor
|
163 |
71K |
4 |
10/11/17 |
10/11/17 |
ASX - By Stock
|
163
|
71K
|
4
|
|
ASX - By Stock
|
1AI |
2 questions, did anyone reduce/increase their meds in any group
|
|
oldinvestor
|
0 |
408 |
1 |
10/11/17 |
10/11/17 |
ASX - By Stock
|
0
|
408
|
1
|
|
ASX - By Stock
|
1AI |
Re:
News: LCT Living Cell Technologies meets 3 of 4 endpoints in study of NTCELL for Parkinson's...
|
|
oldinvestor
|
1 |
569 |
1 |
10/11/17 |
10/11/17 |
ASX - By Stock
|
1
|
569
|
1
|
|
ASX - By Stock
|
1AI |
Re:
Ann: Trading Halt
|
|
oldinvestor
|
53 |
28K |
1 |
10/11/17 |
10/11/17 |
ASX - By Stock
|
53
|
28K
|
1
|
|
ASX - By Stock
|
1AI |
Re:
Ann: Trading Halt
|
|
oldinvestor
|
53 |
28K |
0 |
10/11/17 |
10/11/17 |
ASX - By Stock
|
53
|
28K
|
0
|
|
ASX - By Stock
|
1AI |
Re:
Ann: Trading Halt
|
|
oldinvestor
|
53 |
28K |
1 |
10/11/17 |
10/11/17 |
ASX - By Stock
|
53
|
28K
|
1
|
|
ASX - By Stock
|
1AI |
Re:
Ann: Trading Halt
|
|
oldinvestor
|
53 |
28K |
2 |
10/11/17 |
10/11/17 |
ASX - By Stock
|
53
|
28K
|
2
|
|
ASX - By Stock
|
1AI |
does anyone think results will be publicized before the investor conference starts?
|
|
oldinvestor
|
2 |
1.3K |
0 |
10/11/17 |
10/11/17 |
ASX - By Stock
|
2
|
1.3K
|
0
|
|
ASX - By Stock
|
1AI |
repeating that they treated both sides of the brain with the same ntcell qty as phase1
|
|
oldinvestor
|
1 |
865 |
10 |
09/11/17 |
09/11/17 |
ASX - By Stock
|
1
|
865
|
10
|
|
ASX - By Stock
|
1AI |
Re:
New High
|
|
oldinvestor
|
196 |
75K |
11 |
31/10/17 |
31/10/17 |
ASX - By Stock
|
196
|
75K
|
11
|
|
ASX - By Stock
|
1AI |
Re:
phase II Vs phase I
|
|
oldinvestor
|
46 |
14K |
2 |
26/10/17 |
26/10/17 |
ASX - By Stock
|
46
|
14K
|
2
|
|
ASX - By Stock
|
1AI |
Re:
phase II Vs phase I
|
|
oldinvestor
|
46 |
14K |
4 |
25/10/17 |
25/10/17 |
ASX - By Stock
|
46
|
14K
|
4
|
|
ASX - By Stock
|
1AI |
good article on DBS technology, costs, annual sales
|
|
oldinvestor
|
0 |
390 |
3 |
25/10/17 |
25/10/17 |
ASX - By Stock
|
0
|
390
|
3
|
|
ASX - By Stock
|
1AI |
Re:
New High
|
|
oldinvestor
|
196 |
75K |
11 |
21/10/17 |
21/10/17 |
ASX - By Stock
|
196
|
75K
|
11
|
|
ASX - By Stock
|
1AI |
Re:
New High
|
|
oldinvestor
|
196 |
75K |
10 |
21/10/17 |
21/10/17 |
ASX - By Stock
|
196
|
75K
|
10
|
|
ASX - By Stock
|
1AI |
Re:
New High
|
|
oldinvestor
|
196 |
75K |
13 |
20/10/17 |
20/10/17 |
ASX - By Stock
|
196
|
75K
|
13
|
|
ASX - By Stock
|
1AI |
keep in mind that the phase1 trial only treated one side of the putamen
|
|
oldinvestor
|
1 |
1.0K |
10 |
20/10/17 |
20/10/17 |
ASX - By Stock
|
1
|
1.0K
|
10
|
|
ASX - By Stock
|
1AI |
Re:
newbie from the U.S.
|
|
oldinvestor
|
33 |
12K |
2 |
17/10/17 |
17/10/17 |
ASX - By Stock
|
33
|
12K
|
2
|
|
ASX - By Stock
|
1AI |
Re:
newbie from the U.S.
|
|
oldinvestor
|
33 |
12K |
0 |
17/10/17 |
17/10/17 |
ASX - By Stock
|
33
|
12K
|
0
|
|
ASX - By Stock
|
1AI |
Re:
Annual Report release
|
|
oldinvestor
|
9 |
2.4K |
1 |
16/10/17 |
16/10/17 |
ASX - By Stock
|
9
|
2.4K
|
1
|
|